cnbc.com_2 on Nostr: Bullet points of Biden administration to release prices for first 10 drugs subject to ...
Bullet points of Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
- The 10 drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and NovoLog
- The negotiations are expected to save money for people enrolled in Medicare, who take an average of four to five prescription drugs a month
- The price talks are expected to save Medicare enrollees $1.5 billion in out-of-pocket costs in 2026 alone
- The 10 drugs are among the top 50 with the highest spending for Medicare Part D
- The negotiations are the centerpiece of the Biden administration's efforts to rein in the rising cost of medications in the U.S.
Published at
2024-08-18 11:22:06Event JSON
{
"id": "6788e492390ffeb2e8cd1ec81884caa2ded76eb4a1dc7983f4377b218da8b7d7",
"pubkey": "e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a",
"created_at": 1723980126,
"kind": 1,
"tags": [
[
"subject",
"Bullet points of Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations"
],
[
"p",
"e9d555fcc508b077f9adb908fb97770593291651d3c4ae96d8d9a04d2312ba7a"
],
[
"e",
"1cb6c2a1e5c400b2b72b89fbc7b86937cecddd6b4d8060414fbc59c299df09f3",
"wss://articles.layer3.news",
"root"
]
],
"content": "Bullet points of Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations\n- The 10 drugs are Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara, and Fiasp and NovoLog\n- The negotiations are expected to save money for people enrolled in Medicare, who take an average of four to five prescription drugs a month\n- The price talks are expected to save Medicare enrollees $1.5 billion in out-of-pocket costs in 2026 alone\n- The 10 drugs are among the top 50 with the highest spending for Medicare Part D\n- The negotiations are the centerpiece of the Biden administration's efforts to rein in the rising cost of medications in the U.S.\n",
"sig": "c620e063c758e895af449622f72f96b24f0375f4d1654ef9cb021bcc97eae5be22ecd85ee59718b8bc8b3071d7d919770518bdf6591eeb9b350f80a104234b06"
}